Chronic Kidney Disease

Statin Helps Diabetics Who Have Low GFR

CHICAGO—Atorvastatin (Lipitor) is as effective in preventing major cardiovascular events in type 2 diabetics who have impaired renal function as it is in those with normal renal function, according to data presented here at the 67th Scientific Sessions of the American Diabetes Association.

Combination Therapy Benefits Fabry Disease Patients

Combining an ACE inhibitor (ACEI) and angiotensin-receptor blocker (ARB) with enzyme replacement therapy using agalsidase-beta (Fabrazyme, Genzyme) may help stop progressive loss of kidney function in patients with severe kidney involvement due to Fabry disease, researchers report.

Office BP Predicts Microalbuminuria

High ambulatory but normal or well-controlled office BP, a condition known as “reverse white-coat hypertension,” is an independent risk factor for microalbuminuria in patients with treated hypertension.

Next post in News